T. Rowe Price Associates’s Stereotaxis STXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Buy
140,702
+23,781
+20% +$44.6K ﹤0.01% 2944
2026
Q1
$216K Buy
116,921
+21,700
+23% +$47.6K ﹤0.01% 2819
2025
Q4
$220K Buy
95,221
+10,235
+12% +$27.3K ﹤0.01% 2781
2025
Q3
$265K Hold
84,986
– – ﹤0.01% 2663
2025
Q2
$181K Buy
84,986
+4,974
+6% +$10.1K ﹤0.01% 2752
2025
Q1
$141K Hold
80,012
– – ﹤0.01% 2751
2024
Q4
$183K Buy
80,012
+3,813
+5% +$7.97K ﹤0.01% 2718
2024
Q3
$156K Hold
76,199
– – ﹤0.01% 2737
2024
Q2
$139K Buy
76,199
+17,799
+30% +$39.9K ﹤0.01% 2686
2024
Q1
$153K Hold
58,400
– – ﹤0.01% 2692
2023
Q4
$103K Hold
58,400
– – ﹤0.01% 2715
2023
Q3
$93K Hold
58,400
– – ﹤0.01% 2682
2023
Q2
$90K Hold
58,400
– – ﹤0.01% 2718
2023
Q1
$120K Buy
58,400
+12,100
+26% +$27.2K ﹤0.01% 2650
2022
Q4
$96K Buy
46,300
+12,700
+38% +$24.8K ﹤0.01% 2726
2022
Q3
$61K Buy
33,600
+15,800
+89% +$33.9K ﹤0.01% 2807
2022
Q2
$33K Sell
17,800
-4,576
-20% -$10.9K ﹤0.01% 2904
2022
Q1
$83K Buy
22,376
+5,721
+34% +$27K ﹤0.01% 2874
2021
Q4
$103K Sell
16,655
-1,000
-6% -$5.98K ﹤0.01% 2867
2021
Q3
$95K Sell
17,655
-300
-2% -$2.26K ﹤0.01% 2859
2021
Q2
$173K Buy
17,955
+1,506
+9% +$11.9K ﹤0.01% 2760
2021
Q1
$111K Buy
+16,449
New +$97.6K ﹤0.01% 2773

Other funds holding STXS

T. Rowe Price Associates's STXS Position: Q2 2026 in Review

T. Rowe Price Associates increased its Stereotaxis (STXS) stake by 20% in Q2 2026, buying an estimated $44.6K and bringing the position to 140,702 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #2944.

T. Rowe Price Associates first reported a position in STXS in Q1 2021 and has held it in 22 quarters since. The position peaked at $265K in Q3 2025. 108 funds tracked by Wall St. Rank hold STXS as of Q2 2026.

  • T. Rowe Price Associates held 140,702 shares of Stereotaxis worth $243K as of Q2 2026.
  • T. Rowe Price Associates bought 23,781 Stereotaxis shares in Q2 2026, an estimated $44.6K.
  • Stereotaxis made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2944 holding.
  • T. Rowe Price Associates first reported a position in Stereotaxis in Q1 2021 and has held it in 22 quarters since.
  • T. Rowe Price Associates's Stereotaxis position peaked at $265K in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Stereotaxis as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.